The MOVE-Rehab study
Research type
Research Study
Full title
Randomized parallel-group study evaluating the effectiveness and cost-effectiveness of the co-administration of MindMOtionPRO plus standard practice VErsus standard practice in early post-stroke upper-limb rehabilitation – The MOVE-Rehab study
IRAS ID
199985
Contact name
Jesse Dawson
Contact email
Sponsor organisation
MindMaze SA
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
The goal of the study is to show that MindMotionPRO is a tool that allows a patient to increase the amount of rehabilitation therapy performed. This study will measure the rehabilitation dose, as measured by the duration of the rehabilitation session and the number of exercises performed by the patient. The study hypothesis is that patients in the MindMotionPRO group will spend more time performing rehabilitation exercises than in the Self-Directed Prescribed exercises group. The effectiveness of the MindMotionPRO versus Self-Directed Prescribed Exercises will also be measured, based on the change in rehabilitation performance measures. The cost-effectiveness will be measured by the resource utilization, as defined by the time spent by the therapist providing the rehabilitation session.
REC name
West of Scotland REC 5
REC reference
16/WS/0085
Date of REC Opinion
2 Jun 2016
REC opinion
Further Information Favourable Opinion